Dexmedetomidine for treatment of hyperactive delirium in non-intubated ICU patients: the 4D randomized clinical trial.

Intensive Care Med · 2025 · PMC12678554 · PMID 41160116

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Ninth, while being numerically more frequent in the dexmedetomidine group, adverse events exploratory outcomes did not reach statistical significance, and thus must be interpreted with caution.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.